Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aki Furusawa

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 14, 2022
Quantitative Assessment of the Efficacy of Near-Infrared Photoimmunotherapy with Bioluminescence ImagingRyuhei Okada, Aki Furusawa, Peter L Choyke, et al.
International Immunology|June 5, 2020
Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunityHisataka Kobayashi, Aki Furusawa, Adrian Rosenberg, et al.
Cancers|November 14, 2023
Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell CarcinomaNanami L Miyazaki, Aki Furusawa, Peter L Choyke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2017
Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer ImmunotherapyAki Furusawa, John Reiser, Kavitha Sadashivaiah, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 2, 2024
[Novel Therapy Targeting the Cancer Microenvironment Using Near-Infrared Photoimmunotherapy Leading to Tumor Immune Activation]Takuya Kato, Kazuhiro Noma, Aki Furusawa, et al.
Cellular Immunology|December 12, 2018
Eomesodermin driven IL-10 production in effector CD8<sup>+</sup> T cells promotes a memory phenotypeJohn Reiser, Kavitha Sadashivaiah, Aki Furusawa, et al.
Cancers|June 2, 2021
Near Infrared Photoimmunotherapy; A Review of Targets for Cancer TherapyTakuya Kato, Hiroaki Wakiyama, Aki Furusawa, et al.
Nanophotonics (Berlin, Germany)|November 21, 2022
Near infrared photoimmunotherapy of cancer; possible clinical applicationsHiroaki Wakiyama, Takuya Kato, Aki Furusawa, et al.
Oncoimmunology|May 3, 2014
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapyChang Song, Kavitha Sadashivaiah, Aki Furusawa, et al.
Oncotarget|April 24, 2018
STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphomaHaley M Simpson, Aki Furusawa, Kavitha Sadashivaiah, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|July 14, 2022
Quantitative Assessment of the Efficacy of Near-Infrared Photoimmunotherapy with Bioluminescence ImagingRyuhei Okada, Aki Furusawa, Peter L Choyke, et al.
International Immunology|June 5, 2020
Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunityHisataka Kobayashi, Aki Furusawa, Adrian Rosenberg, et al.
Cancers|November 14, 2023
Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell CarcinomaNanami L Miyazaki, Aki Furusawa, Peter L Choyke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2017
Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer ImmunotherapyAki Furusawa, John Reiser, Kavitha Sadashivaiah, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 2, 2024
[Novel Therapy Targeting the Cancer Microenvironment Using Near-Infrared Photoimmunotherapy Leading to Tumor Immune Activation]Takuya Kato, Kazuhiro Noma, Aki Furusawa, et al.
Cellular Immunology|December 12, 2018
Eomesodermin driven IL-10 production in effector CD8<sup>+</sup> T cells promotes a memory phenotypeJohn Reiser, Kavitha Sadashivaiah, Aki Furusawa, et al.
Cancers|June 2, 2021
Near Infrared Photoimmunotherapy; A Review of Targets for Cancer TherapyTakuya Kato, Hiroaki Wakiyama, Aki Furusawa, et al.
Nanophotonics (Berlin, Germany)|November 21, 2022
Near infrared photoimmunotherapy of cancer; possible clinical applicationsHiroaki Wakiyama, Takuya Kato, Aki Furusawa, et al.
Oncoimmunology|May 3, 2014
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapyChang Song, Kavitha Sadashivaiah, Aki Furusawa, et al.
Oncotarget|April 24, 2018
STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphomaHaley M Simpson, Aki Furusawa, Kavitha Sadashivaiah, et al.
Pageof 7